monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-CL interface
External Resource: Annotation
Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
---|
A [auth H] | Heavy Chain | IGHV3 | - | - | SAbDab (2025-09-26) |
B [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2025-09-26) |
Chain | Name | Target | Provenance Source |
---|
A [auth H] | Vislarafusp | SIRPA, ERBB2/CD340/HER2, CD3E, TNFRSF9/CD137/4-1BB | Therapeutic SAbDab (2025-09-26) |
B [auth L] | Caxmotabart | ERBB2/CD340/HER2, SIRPA, CD3E, TNFRSF9/CD137/4-1BB | Therapeutic SAbDab (2025-09-26) |